Filter by
Selections
May 6, 2015
Arrowhead Presents Data on Potential RNAi Candidate Targeting Factor 12 Mediated Angioedemic and Thromboembolic Diseases
Read MoreMay 5, 2015
Arrowhead Completes Dosing Healthy Volunteers and Initiates Transition to Patients in Phase 1 Study of ARC-AAT
Read MoreFebruary 23, 2015